Connect with us

Health

Walmart to Sell InnerScope’s Hearing Aids to Customers

Published

on

By Dipo Olowookere

InnerScope Hearing Technologies Inc. (INND) has announced that Walmart has successfully launched the company’s FDA-Registered Hearing Aids and its Personal Sound Amplifier Products (PSAPs) to be sold Direct-To-Consumer to Walmart’s online customers.

A statement issued by INND disclosed that as a contract supplier and a direct ship vendor aka drop ship vendor (DSV) for Walmart, it has been preparing for the launch by ramping-up multiple skews of its PSAPs and hearing aid device inventory, ready to be shipped directly to Walmart customers upon order.

The company prides itself on continuing to deliver on its mission by providing Direct-To-Consumer easy access of the latest in high quality hearing aid technology at very affordable prices.

Walmart along with InnerScope is continuing to enhance the format, language and listing for all of the company’s products on the web pages on Walmart.

These enhancements will allow Walmart’s customers to have increased visibility and understanding of the differences between each hearing product listing for ease of ordering.

InnerScope as a DSV supplier to Walmart promised to continue to add more high quality hearing aid and hearing assistive products to Walmart’s listing and web pages.

The ALPHA’s are a very small discreet compact design and comfortable with Bluetooth Low Energy (BLE) wireless technology (for direct connection to external Bluetooth-enable devices) with a user app for added user control and personalizing the hearing aids for all different environments via Android or iOS Smartphone’s. The ALPHA Series with Bluetooth and a Smart Control App is offered in 3 levels of technology based on affordability and hearing needs.

The ALPHA 3 hearing aid has a digital processor that consists of 4-channels and 8-frequency bands with 4 separated user programs. The ALPHA 3 is suitable for mild to moderately severe hearing losses and includes a Basic Instantaneous Noise and Surround Sound Processor. The APLHA 3 offers Best-Value and affordability with its basic features designed for moderately active lifestyles.

The ALPHA 5 hearing aid has a digital processor that consists of 12-channels and 16-frequency bands with 5 separated user programs. The ALPHA 5 is suitable for mild to moderately severe hearing losses and includes an Automatic Intelligent Switching for Different Environments, Advanced Instantaneous Noise and Surround Sound Processor. The APLHA 5 and its Advanced features are designed for more active lifestyles that requires hearing in many different environments.

The ALPHA 9 hearing aid has a digital processor that consists of 16-channels and 16-frequency bands with 6 separated user programs. The ALPHA 9 is suitable for mild to moderately severe hearing losses and includes Best-in-Class Automatic Intelligent Switching for Different Environments with Instantaneous Noise and Surround Sound Processor. The APLHA 9 and its Best-in-Class features are designed for the most active lifestyles that requires the best opportunity to hear clearly in the most demanding environments.

The Teeny PSAP is a patented audiologist designed ear-level PSAP which uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Teeny is a one size fits all completely-in-the-canal (CIC), made to be comfortably hidden within the ear canal.

The Crescent PSAPa patented audiologist designed ear-level PSAP which also like the Teeny PSAP, uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Crescent with its unique universal shell design fits approximately 95% of all ears.

The BlackCat PSAP is a hearable/wearable personal audio controller designed for people who have difficulty understanding conversation in difficult listening and noisy situations, like in a restaurant or group gatherings. Its compact credit card design and easy to use buttons for the user to control volume, balance and rear noise suppression.

“We could not have been more pleased with working with Walmart.com for helping them to promote our affordable high quality hearing aids and hearing assistive products,” said Matthew Moore, CEO of InnerScope Hearing Technologies. “We are proud to have Walmart.com choose our hearing aids and hearing assistive products for their customers. With the current average cost of hearing aids running about $5000.00, a set, it’s no wonder why, there is only 7 to 8 million Americans that currently use hearing aids when there are over 48 million that have reported some hearing loss and could benefit from using hearing aids or some hearing assistance. InnerScope’s agreement with Walmart, gives the company and Walmart the opportunity to sell the 48 million Americans an affordable alternative to the traditional high cost of hearing aids at 75% to 80% less than the current average cost. Not to mention, the revenue potential is off the charts for both the company and Walmart. Each person has two ears, that’s 96 million potential hearing aid sales,” continued Mr Moore.

“We know the cost of hearing aids is just too high for most people that need them. However, there is even a greater cost that very few ever know about. The “real” cost is much higher than the actual dollars spent. For those approximately 42 million Americans that suffer from hearing loss and could not afford to purchased hearing aids, are potentially at high risk and in-fact, could be jeopardizing their overall health and well-being. Proper auditory stimulation from the use of hearing aids may reduce health issues associated with of untreated hearing loss, including cognitive issues, such as Dementia and Alzheimer’s disease. We believe with Walmart.com as retailer of InnerScope’s hearing products, more people will recognize the need to treat their hearing issues sooner than later and thereby reducing unnecessary health risks, due to untreated hearing loss,” Mr Moore concluded

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Adichie Demands Documentation of Late Son’s Treatment as Euracare Suspends Doctor

Published

on

ngozi adichie propofol

By Adedapo Adesanya

Nigerian author, Ms Chimamanda Ngozi Adichie, via her solicitors, has written to Euracare Multi-Specialist Hospital, Lagos, over the death of her 21-month-old son, Nkanu Nnamdi, seeking documentation of treatment before his untimely demise.

In a legal notice dated January 10, 2026, solicitors acting for the renowned author and her partner, Dr Ivara Esege, alleged that the hospital, its anaesthesiologist, and attending medical personnel breached the duty of care owed to their son, who died in the early hours of Wednesday, January 7, 2026.

The notice was issued on behalf of the parents by Pinheiro LP and signed by the founding partner, Prof Kemi Pinheiro (SAN).

According to the notice, the child was referred to the hospital on January 6, 2026, from Atlantis Pediatric Hospital for a series of diagnostic and preparatory procedures. These included an echocardiogram, a brain MRI, the insertion of a peripherally inserted central catheter (PICC line), and a lumbar puncture.

The procedures were reportedly part of preparations for an imminent medical evacuation to the United States, where a specialist medical team was said to be on standby to receive him.

The solicitors stated that intravenous sedation was administered using propofol.

However, it was alleged that during transportation to the cardiac catheterisation laboratory following the MRI procedure, the child allegedly developed sudden and severe complications.

Despite being under sedation, he was said to have been transferred between clinical areas under conditions that raised “serious and substantive concerns” about compliance with patient-safety protocols.

He was later pronounced dead in the early hours of January 7, 2026.

The legal notice outlines multiple alleged lapses in paediatric anaesthetic and procedural care.

These include concerns about the appropriateness and cumulative dosing of propofol in a critically ill child, inadequate airway protection during deep sedation, and an alleged failure to ensure continuous physiological monitoring.

The parents further alleged that their son was transferred without supplemental oxygen, without adequate monitoring, and without sufficient accompanying medical personnel.

They also raised concerns over the availability of basic resuscitation equipment, delayed recognition and management of respiratory or cardiovascular compromise, and an overall failure to comply with established paediatric anaesthesia, patient-transfer, and safety protocols.

Another major grievance cited was the alleged failure of the hospital to adequately disclose the risks and potential side effects of propofol and other anaesthetic agents, thereby undermining the legal requirement for informed consent.

According to the solicitors, these alleged lapses amount to prima facie breaches of the duty of care and render the hospital and all medical personnel involved liable for medical negligence resulting in the child’s death.

As part of their next legal steps, the parents demanded certified copies of all medical records relating to their son’s treatment within seven days of receipt of the notice.

The requested documents include admission notes, consent forms, pre-anaesthetic assessments, anaesthetic charts, drug administration records, monitoring logs, procedural notes, nursing observations, ICU records, incident reports, and the identities of all medical staff involved.

The demand also covers internal reviews, safety logs from the MRI suite, and any other documentation connected to the child’s care.

The hospital was also formally placed on notice to preserve all relevant evidence, whether physical or electronic.

This includes CCTV footage from procedure rooms and corridors, electronic monitoring data, pharmacy and drug inventory records, crash-cart and emergency equipment logs, as well as internal communications and any morbidity and mortality reviews.

The solicitors warned that “any destruction, alteration, or loss of such evidence after receipt of this letter shall be regarded as suppression or concealment of evidence and obstruction of the course of justice, and will be relied upon accordingly, with attendant legal consequences.”

The letter concluded with a warning that failure or refusal by the hospital to comply with the demands within the stipulated timeframe would leave the parents with no option but to pursue all available legal, regulatory, and judicial remedies against the hospital and all medical personnel involved.

Euracare Hospital had noted in a Saturday statement that it had commenced “a detailed investigation” into the incident in line with its clinical governance standards and best practices, while pledging to engage transparently and responsibly with all relevant clinical and regulatory processes.

Also, the Lagos State Government on Saturday said it began an investigation into the incident, vowing to ensure the full weight of the law is applied.

Speaking yesterday, the Special Adviser to the Lagos State Governor on Health, Dr Kemi Ogunyemi, said the doctor involved in the child’s procedure had been suspended by the hospital’s management, noting that the hospital was cooperating with the government in the investigation.

“The hospital itself is also doing its own internal investigation, and as far as we know, the anaesthesiologist involved has been suspended by the hospital,” she revealed.

Continue Reading

Health

Chinamanda Ngozi Adichie Blames Medical Negligence for Son’s Death

Published

on

Chimamanda Ngozi Adichie

By Adedapo Adesanya

Renowned Nigerian author, Ms Chinamanda Ngozi Adichie, has alleged that medical negligence was responsible for the death of her 21-month-old child.

The child, Nkanu, reportedly passed away on Wednesday, January 7, 2026, after a brief illness.

More details have emerged detailing the circumstances surrounding his death.

According to a leaked internal message sent privately to family members and close friends, Ms Adichie blamed a staff of Euracare Multi-Specialist Hospital, located in Victoria Island, Lagos, for causing the demise of the lad.

“My son would be alive today if not for an incident at Euracare Hospital on January 6th.

“We were in Lagos for Christmas. Nkanu had what we first thought was just a cold, but soon turned into a very serious infection and he was admitted to Atlantis hospital.

“He was to travel to the US the next day, January 7th, accompanied by Travelling Doctors. A team at Johns Hopkins was waiting to receive him in Baltimore. The Hopkins team had asked for a lumbar puncture test and an MRI. The Nigerian team had also decided to put in a ‘central line’ (used to administer iv medications) in preparation for Nkanu’s flight. Atlantis hospital referred us to Euracare Hospital, which was said to be the best place to have the procedures done.

“The morning of the 6th, we left Atlantis hospital for Euracare, Nkanu carried in his father’s arms. We were told he would need to be sedated to prevent him from moving during the MRI and the ‘central line’ procedure.

“I was waiting just outside the theater. I saw people, including Dr M, rushing into the theater and immediately knew something had happened.

“A short time later, Dr M came out and told me Nkanu had been given too much propofol by the anesthesiologist, had become unresponsive and was quickly resuscitated. But suddenly Nkanu was on a ventilator, he was intubated and placed in the ICU. The next thing I heard was that he had seizures. Cardiac arrest. All these had never happened before. Some hours later, Nkanu was gone

“It turns out that Nkanu was NEVER monitored after being given too much propofol. The anesthesiologist had just casually carried Nkanu on his shoulder to the theater, so nobody knows when exactly Nkanu became unresponsive.

“How can you sedate a sick child and neglect to monitor him? Later, after the ‘central line’ procedure, the anesthesiologist casually switched off Nkanu’s oxygen and again decided to carry him on his shoulder to the ICU!

“The anesthesiologist was CRIMINALLY negligent. He was fatally casual and careless with the precious life of a child. No proper protocol was followed.

“We brought in a child who was unwell but stable and scheduled to travel the next day. We came to conduct basic procedures. And suddenly, our beautiful little boy was gone forever. It is like living your worst nightmare. I will never survive the loss of my child.

“We have now heard about two previous cases of this same anesthesiologist overdosing children. Why did Euracare allow him to keep working? This must never happen to another child,” she wrote.

As of press time, it is not clear what the next line of action will be with the revelation.

Continue Reading

Health

SUNU Health Named Most Customer Focused HMO of the Year

Published

on

SUNU Health --logo

By Modupe Gbadeyanka

The decision of the management of SUNU Health Nigeria Limited to adopt the strategy of placing the enrollee and customer at the heart of its operations has started to pay off.

The company was recently announced as Most Customer-Focused Health Insurance Company of the Year at the Customer Service Standard Magazine Awards 2025.

The recognition underscored the company’s success in translating its dedication into tangible enrollee satisfaction and superior market service at the Nigerian Health Maintenance Organisation (HMO) landscape.

It also highlights the organisation’s dedicated efforts in streamlining claims processing, enhancing access to quality healthcare providers, and maintaining transparent, responsive communication channels with its diverse client base across Nigeria.

The accolade further serves as a powerful testament to the successful integration of digital solutions and human-centric service models at SUNU Health.

It positions the firm as a leader not only in providing robust health plans but also in delivering the supportive, personalized care that enrollees truly value.

“Clinching the Most Customer-Focused Health Insurance Company of the Year award is not just an honour; it is a validation of the core philosophy that drives every member of the SUNU Health team.

“We believe that healthcare is fundamentally a service industry, and our success is measured by the well-being and satisfaction of our enrollees,” the chief executive of SUNU Health, Mr Patrick Korie, commented.

“This award reinforces our resolve to continuously innovate and set new benchmarks for customer experience in the Nigerian health insurance sector.

“Our commitment to providing accessible, high-quality, and seamless healthcare solutions remains our top priority as we move into the new year (2026),” he added.

Continue Reading

Trending